April 23, 2021 Melita Sun Jung Email: [***] Re: Amended and Restated Offer of Employment Dear Melita:ShouTi Inc. • February 14th, 2022 • Pharmaceutical preparations • California
As you know, ShouTi Inc., a Delaware corporation (the “Company”), entered into an employment offer letter with you on February 14, 2021 (the “Offer Letter”). You and the Company hereby agree to amend and restate the Offer Letter. The terms and conditions set forth in this letter agreement (the “Agreement”) shall become effective as of the date hereof, and shall supersede and replace the terms and conditions set forth in the Offer Letter.
EMPLOYMENT CONTRACTEmployment Contract • February 14th, 2022 • ShouTi Inc. • Pharmaceutical preparations
SHOUTI INC. EXECUTIVE EMPLOYMENT AGREEMENT for RAYMOND STEVENSExecutive Employment Agreement • February 14th, 2022 • ShouTi Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”), is made and entered into effective as of May 16, 2019 (the “Effective Date”), by and between Raymond Stevens (“Employee”) and ShouTi Inc., a Delaware corporation (the “Company”).
SHANGHAI PREMISES LEASE CONTRACTShanghai Premises Lease Contract • February 14th, 2022 • ShouTi Inc. • Pharmaceutical preparations • Shanghai
THIS CONTRACT is made and entered into by and between Party A and Party B, through mutual friendly negotiation based on the principles of equality, voluntariness, fairness and good faith, regarding the lease by Party A to Party B of the real property which Party A is entitled to lease, in accordance with the Contract Law of the People’s Republic of China and the Regulations of Shanghai Municipality for Premises Lease (hereinafter as “Regulations”), with the terms and conditions as follows.
COLLABORATION AGREEMENTCollaboration Agreement • February 14th, 2022 • ShouTi Inc. • Pharmaceutical preparations • New York
This Collaboration Agreement (the “Agreement”) is effective as of October 9, 2020 (the “Effective Date”) by and between Schrödinger, LLC, a Delaware limited liability company, having an address of 120 West 45th Street, 17th Floor, New York, New York 10036 (“Schrödinger”), and Lhotse Bio, Inc., a Delaware corporation having an address of 611 Gateway Blvd Suite 223, South San Francisco, CA 94080 (“Lhotse”). Each of Schrödinger and Lhotse may hereinafter be referred to as a “party” to this Agreement or collectively as the “parties”.
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • February 14th, 2022 • ShouTi Inc. • Pharmaceutical preparations • California
THIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of July 30, 2021, by and among ShouTi Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), and the investors set forth in Schedule A attached hereto (each, an “Investor” and collectively, the “Investors”).
December 10th, 2021 Daniel Welch Dear Dan:ShouTi Inc. • February 14th, 2022 • Pharmaceutical preparations
We are delighted that you have agreed to join the Board of Directors (the “Board”) of ShouTi Inc. (the “Company”) and to serve as the Chairman of the Board. This letter sets forth the agreement between you and the Company regarding your Board membership (the “Agreement”):
